Tata Consultancy Services (TCS) has launched TCS ADD AgentHub, an enterprise-ready agentic AI platform designed to help pharmaceutical companies deploy artificial intelligence across drug development and pharmacovigilance at scale.

The platform addresses the challenges faced by pharmaceutical companies operating in highly regulated environments, where the adoption of AI requires strong governance, oversight, data security and auditability. Growing data volumes, fragmented technology systems and evolving regulatory requirements have added complexity across clinical development and drug safety processes.

Built on the TCS ADD framework, AgentHub provides a structured environment in which AI agents can operate with defined roles, human oversight and built-in audit capabilities. Pharmaceutical companies can develop and deploy AI agents across clinical and pharmacovigilance workflows, with streamlined integration designed to accelerate adoption while supporting regulatory requirements.

TCS said solutions powered by the platform have demonstrated efficiency improvements across several drug development processes. These include up to 40 percent efficiency gains in clinical data management, up to 30 percent reduction in clinical study build efforts through metadata-driven automation and up to 30 percent cost savings in end-to-end safety case processing. AI-powered safety agents can also reduce quality control efforts by up to 50 percent, according to the company.

AgentHub is designed around a Human plus AI Operating Model, in which AI agents are embedded within enterprise workflows while human teams retain responsibility for governance, oversight and critical decision-making.

Debashis Ghosh, President, Lifesciences and Healthcare, TCS, said the platform is intended to help customers accelerate drug development through a scalable and audit-ready agentic AI workforce. He added that TCS is moving towards autonomous enterprise functions where AI agents work alongside human teams to support innovation in drug development and patient safety.

The platform supports a range of clinical development and pharmacovigilance activities. These include Individual Case Safety Report (ICSR) intake, data entry, coding, review and literature analysis, along with study design, protocol digitisation, clinical data review, SDTM transformation and medical monitoring assistance.

TCS said its catalogue of AI agents can be progressively deployed according to the specific requirements and technology landscape of pharmaceutical organisations. By standardising the deployment of AI agents across critical workflows, AgentHub is aimed at improving productivity while allowing scientific and medical teams to focus on higher-value activities.

The launch forms part of TCS's broader AI-first strategy and its efforts to develop secure, scalable and predictive digital ecosystems for enterprises across industries, including life sciences and healthcare.